Abstract
Many studies have documented that dental diseases were associated with an increased risk of cardiovascular diseases. Aortic arch calcification (AoAC) is a powerful predictor of cardiovascular diseases. However, whether the status of dental health is associated with AoAC is still unknown. 9463 participants over the age of 60 from Shenzhen community centers were included in the cross-sectional analysis. Physical examination data, blood biochemical tests, and AoAC scores calculated by chest radiography were collected and analyzed. Among them, 2630 participants were followed up for AoAC progression up to 36 months. Participants with AoAC suffered more tooth loss than those without AoAC (77.62% vs. 72.91%; p < 0.001). Association rule analysis suggested a strong association between dental diseases and AoAC. Tooth loss or decay increased the risk of AoAC progression (HR 1.459; 95%CI 1.284–1.658) after adjusting other risk factors including renal dysfunction. Dental diseases are potential predictors for AoAC in elderly people, which are independent of renal dysfunction.
Keywords: aortic arch calcification, dental diseases, renal dysfunction
1. Introduction
Cardiovascular disease (CVD) is the leading cause of mortality worldwide. The WHO estimated that, by 2030, CVD would account for more than 23 million deaths per year [1,2]. Aortic artery calcification (AoAC) is recognized as an independent and strong predictor of CVD and major adverse cardiovascular events (MACE) [3]. Epidemiological studies have shown that AoAC increases the risk of cardiovascular events within 10 years by more than three times [4]. AoAC impairs the compliance of the aorta severely and leads to hemodynamic disorder, which further increases left ventricular afterload, decreases the perfusion of coronary artery and organs with high blood flow such as the brain and kidney [5]. The prevalence of AoAC grows with age [6]. Unfortunately, there is still no promising treatment for reversing AoAC so far. Therefore, it is important to explore the potential risk factors and mechanisms of AoAC for early prevention and treatment.
Dental diseases, especially tooth loss and tooth decay, have been shown to be strongly associated with CVD through a variety of mechanisms, including impairing renal function, metabolic homeostasis, and promoting inflammation. Observational studies have found that 90% of renal disease patients suffer from oral symptoms such as tooth loss [7]. Other research documents that tooth loss showed a strong and dose-dependent association with end-stage renal disease [8,9]. The severity of tooth loss may be considered an independent risk indicator for renal dysfunction (eGFR < 60 mL/min/1.73 m2) [8]. The prevalence of vascular calcification in patients with CKD stages 3–5 has been shown to be as high as 79% [10]. However, it remains unclear whether dental diseases could lead to AoAC.
In this study, we conducted the investigation of the association between dental diseases and AoAC based on a community-based population and explored possible mechanisms.
2. Materials and Methods
2.1. Study Population and Data Collection
This population-based study enrolled 10,385 community residents aged over 60 years from Shenzhen Futian district, China, between 2016 and 2019. Demographic, lifestyles, medical history, and physical examination were collected by the electronic medical records. A number of 729 participants were excluded for incomplete chest radiography (X-ray) images for the assessment for AoAC. Eventually, 9463 participants were included in the cross-sectional analysis. Among them, 2630 participants with more than two X-ray aortic calcification scores results and blood biochemical tests were included in the longitudinal analysis. Other excluding criteria include trauma in the jaws and orthodontic treatment, implants and wisdom teeth, history of rheumatologic diseases, or malignancy including adrenocortical carcinoma. All subjects or their agents provided written informed consent. The methods complied with the ethical principles of the Declaration of Helsinki. This study was reviewed and approved by the Ethics Committees of the Eighth Affiliated Hospital, Sun Yat-sen University.
2.2. Demographic Characteristics and Baseline Diameters Measurement
Information was collected with structured standardized community health examination forms and face-to-face interviews by trained interviewers. All participants received a physical examination. Blood samples were collected by peripheral venipuncture for all participants and tested for hematology and serum biochemistry. The arterial blood pressure is measured by a doctor using a mercury sphygmomanometer according to a standardized blood pressure measurement plan, and the same arm is used to measure the blood pressure for each patient 3 times in a row [11]. The estimated glomerular filtration rate (eGFR) was calculated from serum creatinine levels with the adjusted CKD-EPI equation for Chinese [12]. Body mass index (BMI) is calculated as weight divided by the square of height (kg/m2). Current smoking and drinking were self-reported by participants. History of hypertension, diabetes, and hyperlipidemia was from previous diagnosis by physician and based on biochemical results.
2.3. Radiographic Evaluation
AoAC score was measured as calcification in the aortic node region on X-ray. Based on these X-rays, two radiologists who were blind to the personal information of each individual diagnosed the presence of AoAC and calculated the scores, the intraclass correlation coefficient was 0.79, which indicated well consistency [13]. The aortic arch area was divided into 16 equally divided sectors, each sector containing calcified plaque were counted and divided by 16, and the results were expressed as a percentage to indicate the severity of aortic calcification. The detailed method was reported previously [14]. Inconsistent results were calculated by the average of two radiologists as the final result. For participants with multiple records, the AoAC progression was defined as a higher AoAC score than at the baseline.
2.4. Dental Examination
The dental examination included an examination of tooth loss and tooth decay, and collection of history of dental diseases including gingivitis and periodontitis. Tooth loss and tooth decay were visually inspected and recorded by experienced dentists, which excludes implants and wisdom teeth [15].
2.5. Statistical Analysis
Baseline characteristics of participants were described with the mean ± standard deviation (SD) for normally distributed continuous variables, the median (25th, 75th percentile) for non-normally distributed continuous variables, and percentages for categorical variables. Student-t-test, Mann–Whitney U test, Kruskal–Wallis test, and chi-square test were used for comparison between groups.
The Apriori algorithm of association rules was applied to examine the association between potential risk factors and AoAC. Univariate and multivariate logistic analyses were used to investigate the association between tooth loss, tooth decay, and AoAC. The Cox proportional hazards regression was used to explore whether tooth loss or decay affects the hazard of AoAC progression. IBM SPSS Statistics v26 and R were used for data analyses. For all statistical tests, two-tail p-value < 0.05 was the threshold of statistical significance.
3. Results
3.1. Clinical Characteristics of Participants with or without AoAC
The data-screening process is shown in Figure S1. Participants who did not receive X-ray (n = 729), with missing or incorrect records (n = 193) were excluded. Finally, 9463 participants were included in the cross-sectional analysis. The cross-sectional analysis was based on the earliest visit of each individual, and 2630 participants with multiple records were analyzed for the AoAC progression over time.
The clinical characteristics of 9463 participants are shown in Table 1. 8031 were diagnosed with AoAC by X-ray. The mean age of participants was 70.76 years, and 57.5% of them were women. Participants with AoAC tended to be older, female. Interestingly, participants with AoAC were found to be more likely to have tooth loss in dental inspections. In the AoAC group, the proportion of tooth loss is 4.71% higher than non-AoAC, and 1.03% for tooth decay.
Table 1.
Characteristics of participants according to the presence of AoAC.
| All Subjects | Non-AoAC | AoAC | p-Value | |
|---|---|---|---|---|
| Number | 9463 | 1432 | 8031 | |
| Demographics | ||||
| Age, years | 70.76 ± 5.74 | 69.59 ± 4.87 | 70.97 ± 5.86 | <0.001 |
| Female, n (%) | 5441 (57.50) | 717 (50.07) | 4724 (58.82) | <0.001 |
| SBP, mmHg | 136.39 ± 17.47 | 134.90 ± 17.22 | 136.65 ± 17.50 | <0.001 |
| DBP, mmHg | 77.36 ± 10.34 | 77.22 ± 10.39 | 77.39 ± 10.33 | 0.555 |
| BMI, kg/m2 | 24.02 ± 3.13 | 24.07 ± 3.03 | 24.01 ± 3.15 | 0.497 |
| Medical history | ||||
| CHD, n (%) | 906 (9.57) | 136 (9.50) | 770 (9.59) | 0.953 |
| Hypertension, n (%) | 7648 (80.82) | 1082 (75.56) | 6566 (81.76) | <0.001 |
| Diabetes Mellitus, n (%) | 1963 (20.74) | 287 (20.04) | 1676 (20.87) | 0.499 |
| Hyperlipidemia, n (%) | 3627 (38.33) | 470 (32.82) | 3157 (39.31) | <0.001 |
| Dental health | ||||
| Tooth loss, n (%) | 7278 (76.91) | 1044 (72.91) | 6234 (77.62) | <0.001 |
| Tooth decay, n (%) | 1160 (12.26) | 163 (11.38) | 997 (12.41) | 0.292 |
| Tooth loss or decay, n (%) | 7550 (79.78) | 1077 (75.21) | 6473 (80.60) | <0.001 |
| Hematology and biochemical test | ||||
| WBC, 109/L | 6.20 (5.20, 7.20) | 6.20 (5.39, 7.30) | 6.12 (5.20, 7.20) | 0.063 |
| HGB, g/L | 134.43 ± 13.51 | 136.04 ± 13.41 | 134.14 ± 13.51 | <0.001 |
| PLT, 109/L | 208.70 ± 50.04 | 209.98 ± 50.10 | 208.47 ± 50.03 | 0.294 |
| TG, mmol/L | 1.28 (0.94, 1.78) | 1.29 (0.94, 1.78) | 1.28 (0.94, 1.78) | 0.814 |
| TC, mmol/L | 5.03 (4.34, 5.75) | 4.98 (4.32, 5.67) | 5.03 (4.34, 5.76) | 0.075 |
| LDL-C, mmol/L | 2.90 (2.28, 3.55) | 2.88 (2.32, 3.49) | 2.91 (2.27, 3.56) | 0.703 |
| HDL-C, mmol/L | 1.40 (1.19, 1.67) | 1.38 (1.15, 1.61) | 1.41 (1.20, 1.68) | <0.001 |
| FPG, mmol/L | 5.46 (4.94, 6.24) | 5.42 (4.86, 6.21) | 5.46 (4.96, 6.24) | 0.022 |
| eGFR, mL/min/1.73 m2 | 72.95 (64.11, 86.58) | 70.21 (63.55, 77.78) | 73.63 (64.36, 88.18) | <0.001 |
| Lifestyle | ||||
| Smoking, n (%) | 1526 (16.13) | 243 (16.97) | 1283 (15.98) | 0.367 |
| Drinking, n (%) | 2092 (22.11) | 337 (23.53) | 1755 (21.85) | 0.168 |
| Physical activity hours/week, n (%) | 0.122 | |||
| <3 h | 2256 (23.84) | 330 (23.04) | 1926 (23.98) | |
| 3–10 h | 6101 (64.47) | 912 (63.69) | 5189 (64.61) | |
| >10 h | 1106 (11.69) | 190 (13.27) | 916 (11.41) |
Continuous variables are summarized as mean ± standard deviation for normally distributed, and median (25th, 75th percentiles) for non-normally distributed. Categorical variables are summarized as count (percentage). SBP indicates systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; CHD: coronary heart disease; WBC: white blood cell count; HGB: hemoglobin; PLT: platelet; TC: total cholesterol; TG: triglyceride; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; FPG: fasting plasma glucose; eGFR: estimated glomerular filtration rate.
Additionally, we found higher systolic blood pressure and fasting plasma glucose in the AoAC group, and participants in the AoAC group were more likely to be diagnosed with hypertension and hyperlipidemia compared to those without AoAC.
3.2. Association Rule Analysis Suggests a Strong Association between Dental Diseases and AoAC
To further explore potential risk factors associated with AoAC, correlations between 25 clinical indexes were analyzed. Tooth loss, tooth decay, and tooth loss or decay are strongly associated with AoAC (Figure 1). A total of 12 effective association rules were screened as shown in Supplementary Table S1. We identified effective association rules between dental diseases and AoAC, which are stronger than traditional risk factors such as renal dysfunction, smoking, and diabetes.
Figure 1.
Visualization of the association rules based on the Apriori algorithm. The thickness of lines indicates the strength of the association rules. SBP indicates systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; CHD: coronary heart disease; WBC: white blood cell count; HGB: hemoglobin; PLT: platelet; TC: total cholesterol; TG: triglyceride; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; FPG: fasting plasma glucose; eGFR: estimated glomerular filtration rate.
3.3. Dental Diseases Were Independent Risk Factors for AoAC
To further explore the relation between tooth loss and tooth decay with AoAC. Participants were divided into four groups according to the quartiles of the AoAC score to explore the distribution of tooth loss and tooth decay between groups. The severity of AoAC gradually increased from Q1 to Q4. The proportion of participants with tooth loss or tooth decay in each group is shown in Figure 2. The proportion of participants with tooth loss (Q1, 72.91%; Q2, 75.90%; Q3, 77.36%; Q4, 79.33%) was significantly different among four groups (χ2 = 23.56, p < 0.001). The results of the Mantel–Haenszel test (χ2 = 23.56, p < 0.001) showed a significant trend that the proportion of tooth loss increased gradually from Q1 to Q4. The results of pairwise comparisons are also shown in Figure 2. However, there was no significant difference in the proportion of participants with tooth decay among the four groups (χ2 =6.80, p = 0.079).
Figure 2.
The proportion of participants with tooth loss or tooth decay in each group divided with quartiles of AoAC scores. * Bonferroni-adjusted p < 0.05, *** Bonferroni-adjusted p < 0.001.
To further verify whether the association between dental diseases and AoAC was influenced by potential confounders, we performed univariate and multivariate logistic regressions for the presence of AoAC. As shown in Table 2, tooth loss significantly showed a positive association with AoAC presence in the unadjusted model (OR: 1.289, 95% CI: 1.135–1.465, p < 0.001). Compared with participants without tooth loss or tooth decay, tooth loss or decay remained associated with a significantly higher prevalence of AoAC in multivariate model adjusting for demographic data, physical examination results, medical history, and biochemical risk factors (OR: 1.158, 95% CI: 1.010–1.329, p = 0.036). These results suggested that dental diseases were an independent risk factor for AoAC, where the presence of any dental disease increased the risk of AoAC by about 16%.
Table 2.
Odds ratios for the presence of AoAC by dental diseases.
| Variables | OR | 95% CI | p Value |
| Unadjusted | |||
| Tooth loss | 1.289 | 1.135–1.465 | <0.001 |
| Tooth decay | 1.103 | 0.925–1.316 | 0.273 |
| Tooth loss or decay | 1.369 | 1.200–1.563 | <0.001 |
| Model 1 | |||
| Tooth loss | 1.172 | 1.028–1.336 | 0.018 |
| Tooth decay | 1.113 | 0.932–1.329 | 0.236 |
| Tooth loss or decay | 1.248 | 1.090–1.428 | 0.001 |
| Model 2 | |||
| Tooth loss | 1.154 | 1.012–1.317 | 0.032 |
| Tooth decay | 1.091 | 0.913–1.303 | 0.337 |
| Tooth loss or decay | 1.223 | 1.068–1.401 | 0.004 |
| Model 3 | |||
| Tooth loss | 1.110 | 0.971–1.268 | 0.125 |
| Tooth decay | 1.015 | 0.848–1.216 | 0.868 |
| Tooth loss or decay | 1.158 | 1.010–1.329 | 0.036 |
Model 1: adjusted with age, gender, BMI, SBP, DBP, smoking, drinking. Model 2: further adjusted with hypertension, hyperlipidemia, diabetes mellitus. Model 3: further adjusted with TG, LDL-C, HDL-C.FPG, eGFR. OR indicates odds ratio; CI: confidence interval; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; TG: triglyceride; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein; FPG: fasting plasma glucose; eGFR: estimated glomerular filtration rate.
3.4. Dental Diseases Increase the Risk of AoAC Progression Independent of Renal Dysfunction
We further analyzed the risk of AoAC progression over time by dental diseases in participants followed up during the study and with at least two X-rays. AoAC progression was defined as an increase in the AoAC score measured by X-ray. As shown in Figure 3A,C, tooth loss or decay significantly increased the risk of AoAC progression over time, and this effect may be mainly contributed by tooth loss (log-rank p < 0.001 for tooth loss or decay, and tooth loss alone).
Figure 3.
Cumulative incidences of AoAC progression by dental diseases and stratified by renal dysfunction. (A–C) show cumulative incidences of AoAC progression by tooth loss, tooth decay, tooth loss, or decay, respectively, and (D–F) show results stratified by renal dysfunction. The cumulative incidences were estimated with the Kaplan–Meier method and compared with the log-rank test.
In addition, the cumulative incidences of AoAC progression were estimated separately according to renal function stratification. Since AoAC is more prevalent in patients with CKD stage 3 and above, we grouped participants by eGFR using a cutoff point of 60 mL/min/1.73 m2. As shown in Figure 3D–F, tooth loss or decay and tooth loss alone significantly increased the risk of AoAC progression in participants from both groups. While tooth decay was observed to be associated with AoAC progression in the group with eGFR ≥ 60 mL/min/1.73 m2 (log-rank p = 0.026). Baseline characteristics of the participants included in the longitudinal analysis by the dental diseases are shown in Supplementary Tables S2–S4.
To eliminate the effect of potential confounders, we further performed multivariate Cox proportional hazard regressions for AoAC progression, stratified by important risk factors for AoAC.
In the fully adjusted model, and any stratification of established risk factors for AoAC, tooth loss or decay, and tooth loss alone significantly increased the risk of AoAC progression (Figure 4). These results suggested that tooth loss or decay was strong risk factors for AoAC progression, independent of recognized risk factors such as renal dysfunction (p < 0.001). Tooth decay was not included in the analysis due to a violation of the proportional hazard assumption.
Figure 4.
Subgroup analysis of the association of dental diseases and the progression of AoAC. Variables included in the adjusted models include age, sex, BMI, SBP, DBP, smoking, drinking, hypertension, hyperlipidemia, diabetes mellitus, TG, LDL-C, HDL-C, FPG, eGFR. OR indicates odds ratio; CI: confidence interval; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; TG: triglyceride; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein; FPG: fasting plasma glucose; eGFR: estimated glomerular filtration rate. * eGFR was removed from the adjusted variables due to violation of the proportional hazard assumption in subgroups without hypertension and diabetes mellitus. All other models met the proportional hazards assumption tested with Schoenfeld residuals.
4. Discussion
In this study, we aimed to investigate the association between tooth loss, tooth decay, and AoAC in a large-scale community-based population. Our findings suggested dental diseases were independent risk factors for AoAC based on both cross-section analysis and longitudinal analysis, which was not mediated by renal dysfunction. Tooth loss was a more important contributor than tooth decay. Compared with participants without tooth loss or tooth decay, any missing or decayed teeth may increase the risk of AoAC.
Tooth loss is an advanced stage of many dental diseases, including periodontitis and tooth decay, and is considered an effective marker of dental health over the life course [16,17]. Tooth loss also leads to compromised nutrition and a poorer central nervous system function [18]. Tooth loss and tooth decay have also been identified as important risk factors for cardiovascular diseases [19], and tooth loss increases the risk of major cardiovascular events such as myocardial infarction, heart failure, and stroke [20,21]. Tooth loss is in positive correlation with a positive correlation with cardiovascular mortality [22,23]. Previous research reported that tooth loss is correlated to more severe carotid and coronary artery calcification [24,25]. However, after adjusting age, sex, and other well-known risk factors for cardiovascular disease, the significant correlation was no longer present in the multivariate model. This study was based on a larger aged population in China, and identified tooth loss as an independent risk factor for AoAC progression in multivariate analyses adjusted with established AoAC risk factors.
Vascular calcification (VC) is a common and featured arterial pathological condition in chronic kidney disease and diabetes [26,27]. The dental diseases could lead to impaired kidney function [9,28], and are also associated with an increased risk of diabetes [29]. However, our results in this large community-based population suggested that tooth loss or decay was a strong risk factor for AoAC independent of established risk factors, suggesting that other underlying mechanisms remain to be further explored.
Inflammation is an important mechanism that promotes VC [30]. Inflammatory mediators, including interleukin-1β, interleukin-6, and tumor necrosis factor (TNF)-α, could stimulate the transformation of VSMCs from a contractile phenotype to an osteogenic phenotype [31,32]. Dental diseases are associated with a significant increase in the severity of systemic inflammation [33], which may be an important mechanism linking it with VC. However, due to limitations in the range of data, we cannot provide relevant results based on systemic inflammation as evidence. On the other side, VC shares many features with bone development and metabolism. Tooth loss involves alveolar bone loss, which has been reported of a strong association with osteoporosis in previous studies and could be a local reflection of systemic bone loss [34,35]. In this study, there was a higher proportion of elderly women, who are susceptible to osteoporosis, and this proportion was even higher among participants with AoAC. Estrogen changes after menopause may be related to this phenomenon [36]. However, the study population was limited to over 60 years of age, which made it unable to further explore the influence of menopausal status.
In this study, AoAC was measured and scored based on X-rays in the large-scale population. Although CT remains the reference standard for measurement and quantification of VC, its high-cost limits applications in large-scale population examinations [37]. Since the aortic arch has been identified as the most vulnerable site for calcifications in the thoracic aorta [38], the severity of AoAC is indicated by the calcification score in the aortic node region, AoAC score was widely accepted to assess the severity of VC, which has been validated to be a simple, inexpensive, and reliable reflection of AoAC [39].
Our results may provide new perspectives for clinical practice and future research directions. Tooth loss and tooth decay are easy to observe, which may be beneficial to identifying subjects with high cardiovascular risk. Whether dental interventions could reduce VC and improve cardiovascular health needs further research. Since the mechanism of VC has not been elucidated, and there is still a lack of effective treatment, further exploration of the mechanism may provide a new perspective for the prevention and treatment of AC.
5. Conclusions
Dental diseases are potential predictors for AoAC in elderly people, which are independent of renal dysfunction.
6. Limitations
This study has several limitations. Firstly, the number of teeth lost and the severity of tooth decay was not quantified, so the dose–response relationship was not measured further. Secondly, no serological examinations reflected the level of inflammation in this study, therefore the discussion on the mechanism of inflammation lacked support from results.
Acknowledgments
We would like to voice appreciation for Shenzhen Center for Disease Control and Prevention for data support, all subjects and general practitioners who participated in this study, and Jiangang Shen (from State Key Laboratory of Pharmaceutical Biotechnology, and School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong) for their support and improvements to this study.
Supplementary Materials
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/metabo12121258/s1. Figure S1 and Tables S1–S5 are available in the supplementary data.
Author Contributions
Conceptualization, H.H.; Data curation, L.Y. and D.L.; Formal analysis, L.Y., Z.Z. and W.H.; Funding acquisition, H.H.; Investigation, L.Y.; Methodology, Z.Z., W.H. and S.H.; Project administration, H.H.; Resources, C.X.; Software, S.H.; Supervision, S.H.; Validation, Z.Z. and D.L.; Visualization, L.Y., Z.Z. and C.X.; Writing—original draft, L.Y.; Writing—review and editing, Z.Z. and H.H. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
All subjects or their agents provided written informed consent. The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committees of the Eighth Affiliated Hospital, Sun Yat-sen University (protocol code: 2021-034-01; 2021-09-23).
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
Not applicable.
Conflicts of Interest
The authors declare no conflict of interest.
Funding Statement
This work was supported in part by National Key Research and Development Program (2020YFC2004405), National Nature Science Foundation of China (82061160372, 82270771 and 81870506), Central Military Commission Key Project of Basic Research for Application (BWJ21J003), Regional Joint Funding Key Project of Guangdong Basic Research and Basic Research for Application (2021B1515120083), Key Project of Sustainable Development Science and Technology of Shenzhen Science and Technology Innovation Committee (KCXFZ20211020163801002), Basic Research Project of Shenzhen Science and Technology Innovation Committee (JCYJ20180306174648342 and JCYJ20190808102005602), and Shenzhen Key Medical Discipline Construction Fund (SZXK002) to H.H.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Colantonio L.D., Muntner P. It Is Time for Reducing Global Cardiovascular Mortality. Circulation. 2019;140:726–728. doi: 10.1161/CIRCULATIONAHA.119.041653. [DOI] [PubMed] [Google Scholar]
- 2.Roth G.A., Mensah G.A., Johnson C.O., Addolorato G., Ammirati E., Baddour L.M., Barengo N.C., Beaton A.Z., Benjamin E.J., Benziger C.P., et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J. Am. Coll. Cardiol. 2020;76:2982–3021. doi: 10.1016/j.jacc.2020.11.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ghosh S., Luo D., He W., Chen J., Su X., Huang H. Diabetes and calcification: The potential role of anti-diabetic drugs on vascular calcification regression. Pharmacol. Res. 2020;158:104861. doi: 10.1016/j.phrs.2020.104861. [DOI] [PubMed] [Google Scholar]
- 4.Duan M., Zhao W.-L., Zhou L., Novák P., Zhu X., Yin K. Omics research in vascular calcification. Clin. Chim. Acta. 2020;511:319–328. doi: 10.1016/j.cca.2020.10.022. [DOI] [PubMed] [Google Scholar]
- 5.Di Minno M.N.D., Poggio P., Conte E., Myasoedova V., Songia P., Mushtaq S., Cavallotti L., Moschetta D., Di Minno A., Spadarella G., et al. Cardiovascular morbidity and mortality in patients with aortic valve calcification: A systematic review and meta-analysis. J. Cardiovasc. Comput. Tomogr. 2019;13:190–195. doi: 10.1016/j.jcct.2019.06.006. [DOI] [PubMed] [Google Scholar]
- 6.Bartstra J.W., Mali W.P.T.M., Spiering W., de Jong P.A. Abdominal aortic calcification: From ancient friend to modern foe. Eur. J. Prev. Cardiol. 2021;28:1386–1391. doi: 10.1177/2047487320919895. [DOI] [PubMed] [Google Scholar]
- 7.Yuan Q., Xiong Q.-C., Gupta M., López-Pintor R.M., Chen X.-L., Seriwatanachai D., Densmore M., Man Y., Gong P. Dental implant treatment for renal failure patients on dialysis: A clinical guideline. Int. J. Oral Sci. 2017;9:125–132. doi: 10.1038/ijos.2017.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Choi H.M., Han K., Park Y.G., Park J.-B. Associations between the number of natural teeth and renal dysfunction. Medicine. 2016;95:e4681. doi: 10.1097/MD.0000000000004681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Han K., Park J.-B. Tooth loss and risk of end-stage renal disease: A nationwide cohort study. J. Periodontol. 2021;92:371–377. doi: 10.1002/JPER.19-0679. [DOI] [PubMed] [Google Scholar]
- 10.Levy D.S., Grewal R., Le T.H. Vitamin K deficiency: An emerging player in the pathogenesis of vascular calcification and an iatrogenic consequence of therapies in advanced renal disease. Am. J. Physiol. Renal Physiol. 2020;319:F618–F623. doi: 10.1152/ajprenal.00278.2020. [DOI] [PubMed] [Google Scholar]
- 11.Muntner P., Shimbo D., Carey R.M., Charleston J.B., Gaillard T., Misra S., Myers M.G., Ogedegbe G., Schwartz J.E., Townsend R.R., et al. Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association. Hypertension. 2019;73:e35–e66. doi: 10.1161/HYP.0000000000000087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Teo B.W., Xu H., Wang D., Li J., Sinha A.K., Shuter B., Sethi S., Lee E.J.C. GFR estimating equations in a multiethnic Asian population. Am. J. Kidney Dis. 2011;58:56–63. doi: 10.1053/j.ajkd.2011.02.393. [DOI] [PubMed] [Google Scholar]
- 13.Prieto L., Lamarca R., Casado A., Alonso J. The evaluation of agreement on continuous variables by the intraclass correlation coefficient. J. Epidemiol. Community Health. 1997;51:579–581. doi: 10.1136/jech.51.5.579-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ogawa T., Ishida H., Matsuda N., Fujiu A., Matsuda A., Ito K., Ando Y., Nitta K. Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patients. Hemodial. Int. 2009;13:301–306. doi: 10.1111/j.1542-4758.2009.00366.x. [DOI] [PubMed] [Google Scholar]
- 15.Shin H.-S. Number of existing permanent teeth is associated with chronic kidney disease in the elderly Korean population. Korean J. Intern. Med. 2018;33:1150–1159. doi: 10.3904/kjim.2016.386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Morelli T., Agler C.S., Divaris K. Genomics of periodontal disease and tooth morbidity. Periodontol. 2000. 2020;82:143–156. doi: 10.1111/prd.12320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kinane D.F., Stathopoulou P.G., Papapanou P.N. Periodontal diseases. Nat. Rev. Dis. Primers. 2017;3:17038. doi: 10.1038/nrdp.2017.38. [DOI] [PubMed] [Google Scholar]
- 18.Thomson W.M., Barak Y. Tooth Loss and Dementia: A Critical Examination. J. Dent. Res. 2021;100:226–231. doi: 10.1177/0022034520957233. [DOI] [PubMed] [Google Scholar]
- 19.Ylöstalo P.V., Järvelin M.R., Laitinen J., Knuuttila M.L. Gingivitis, dental caries and tooth loss: Risk factors for cardiovascular diseases or indicators of elevated health risks. J. Clin. Periodontol. 2006;33:92–101. doi: 10.1111/j.1600-051X.2005.00875.x. [DOI] [PubMed] [Google Scholar]
- 20.Lee H.J., Choi E.K., Park J.B., Han K.D., Oh S. Tooth Loss Predicts Myocardial Infarction, Heart Failure, Stroke, and Death. J. Dent. Res. 2019;98:164–170. doi: 10.1177/0022034518814829. [DOI] [PubMed] [Google Scholar]
- 21.Vedin O., Hagström E., Östlund O., Avezum A., Budaj A., Flather M.D., Harrington R.A., Koenig W., Soffer J., Siegbahn A., et al. Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease. Int. J. Cardiol. 2017;245:271–276. doi: 10.1016/j.ijcard.2017.07.036. [DOI] [PubMed] [Google Scholar]
- 22.Beukers N.G.F.M., Su N., Loos B.G., van der Heijden G.J.M.G. Lower Number of Teeth Is Related to Higher Risks for ACVD and Death-Systematic Review and Meta-Analyses of Survival Data. Front. Cardiovasc. Med. 2021;8:621626. doi: 10.3389/fcvm.2021.621626. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Polzer I., Schwahn C., Völzke H., Mundt T., Biffar R. The association of tooth loss with all-cause and circulatory mortality. Is there a benefit of replaced teeth? A systematic review and meta-analysis. Clin. Oral Investig. 2012;16:333–351. doi: 10.1007/s00784-011-0625-9. [DOI] [PubMed] [Google Scholar]
- 24.Donders H.C.M., LM I.J., Soffner M., van ’t Hof A.W.J., Loos B.G., de Lange J. Elevated Coronary Artery Calcium scores are associated with tooth loss. PLoS ONE. 2020;15:e0243232. doi: 10.1371/journal.pone.0243232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Holmlund A., Lind L. Number of teeth is related to atherosclerotic plaque in the carotid arteries in an elderly population. J. Periodontol. 2012;83:287–291. doi: 10.1902/jop.2011.110100. [DOI] [PubMed] [Google Scholar]
- 26.Lanzer P., Hannan F.M., Lanzer J.D., Janzen J., Raggi P., Furniss D., Schuchardt M., Thakker R., Fok P.-W., Saez-Rodriguez J., et al. Medial Arterial Calcification: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2021;78:1145–1165. doi: 10.1016/j.jacc.2021.06.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Yao H., Sun Z., Zang G., Zhang L., Hou L., Shao C., Wang Z. Epidemiological Research Advances in Vascular Calcification in Diabetes. J. Diabetes Res. 2021;2021:4461311. doi: 10.1155/2021/4461311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wangerin C., Pink C., Endlich K., Rettig R., Stracke S., Nauck M., Völzke H., Kocher T., Holtfreter B. Long-term Association of Periodontitis With Decreased Kidney Function. Am. J. Kidney Dis. 2019;73:513–524. doi: 10.1053/j.ajkd.2018.10.013. [DOI] [PubMed] [Google Scholar]
- 29.Chang Y., Lee J.S., Lee K.-J., Woo H.G., Song T.-J. Improved oral hygiene is associated with decreased risk of new-onset diabetes: A nationwide population-based cohort study. Diabetologia. 2020;63:924–933. doi: 10.1007/s00125-020-05112-9. [DOI] [PubMed] [Google Scholar]
- 30.Lee H.Y., Lim S., Park S. Role of Inflammation in Arterial Calcification. Korean Circ. J. 2021;51:114–125. doi: 10.4070/kcj.2020.0517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Shen J., Zhao M., Zhang C., Sun X. IL-1β in atherosclerotic vascular calcification: From bench to bedside. Int. J. Biol. Sci. 2021;17:4353–4364. doi: 10.7150/ijbs.66537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Zeb I., Jorgensen N.W., Blumenthal R.S., Burke G.L., Lloyd-Jones D., Blaha M.J., Wong N.D., Nasir K., Budoff M.J. Association of inflammatory markers and lipoprotein particle subclasses with progression of coronary artery calcium: The multi-ethnic study of atherosclerosis. Atherosclerosis. 2021;339:27–34. doi: 10.1016/j.atherosclerosis.2021.11.003. [DOI] [PubMed] [Google Scholar]
- 33.López-Mejías R., González-Gay M.A. IL-6: Linking chronic inflammation and vascular calcification. Nat. Rev. Rheumatol. 2019;15:457–459. doi: 10.1038/s41584-019-0259-x. [DOI] [PubMed] [Google Scholar]
- 34.Yu B., Wang C.Y. Osteoporosis and periodontal diseases—An update on their association and mechanistic links. Periodontol. 2000. 2022;89:99–113. doi: 10.1111/prd.12422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Nicopoulou-Karayianni K., Tzoutzoukos P., Mitsea A., Karayiannis A., Tsiklakis K., Jacobs R., Lindh C., van der Stelt P., Allen P., Graham J., et al. Tooth loss and osteoporosis: The OSTEODENT Study. J. Clin. Periodontol. 2009;36:190–197. doi: 10.1111/j.1600-051X.2008.01365.x. [DOI] [PubMed] [Google Scholar]
- 36.Taguchi A., Kobayashi J., Suei Y., Ohtsuka M., Tanimoto K., Sanada M., Ohama K. Relationship between estrogen-receptor genotype and tooth loss in postmenopausal women. JAMA. 2001;286:2234–2235. doi: 10.1001/jama.286.18.2234. [DOI] [PubMed] [Google Scholar]
- 37.Karohl C., D’Marco Gascón L., Raggi P. Noninvasive imaging for assessment of calcification in chronic kidney disease. Nat. Rev. Nephrol. 2011;7:567–577. doi: 10.1038/nrneph.2011.110. [DOI] [PubMed] [Google Scholar]
- 38.Ma X., Hou F., Tian J., Zhou Z., Ma Y., Cheng Y., Du Y., Shen H., Hu B., Wang Z., et al. Aortic Arch Calcification Is a Strong Predictor of the Severity of Coronary Artery Disease in Patients with Acute Coronary Syndrome. BioMed Res. Int. 2019;2019:7659239. doi: 10.1155/2019/7659239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Chung T.-L., Liu Y.-H., Huang J.-C., Wu P.-Y., Tu H.-P., Chen S.-C., Chang J.-M. Prognostic Implication of Longitudinal Changes in Cardiothoracic Ratio and Aortic Arch Calcification in Hemodialysis Patients. J. Pers. Med. 2021;11:788. doi: 10.3390/jpm11080788. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Not applicable.




